SKI Market

A+| A| A-|

Indian Indices

Sensex

78,151.45 964.58
( 1.25%)

Global Indices

Nasdaq

52,169.86 -404.11
(-0.77%)

Dow Jones

7,480.34 -74.43
(-0.99%)

Hang Seng

63,887.74 -2,947.80
(-4.41%)

Nikkei 225

10,574.52 2.28
(0.02%)

Forex

USD-INR

96.36 0.10
(0.10%)

EUR-INR

110.37 0.25
(0.23%)

GBP-INR

130.11 0.62
(0.47%)

JPY-INR

0.59 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cohance Lifesciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543064

INE03QK01018

117.1064173

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

COHANCE

67.48

16884.6

EPS(TTM)

Face Value()

Div & Yield %

6.54

Back

xl energy ltd

Cupid consolidated net profit rises 196.30% in the December 2025 quarter

Jan 30,2026

Net profit of Cupid rose 196.30% to Rs 32.83 crore in the quarter ended December 2025 as against Rs 11.08 crore during the previous quarter ended December 2024. Sales rose 101.73% to Rs 93.50 crore in the quarter ended December 2025 as against Rs 46.35 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	93.50	46.35	102
OPM %	36.68	24.55	-
PBDT	44.58	15.39	190
PBT	43.27	14.10	207
NP	32.83	11.08	196

78,151.45 964.58 ( 1.25%)

52,169.86 -404.11 (-0.77%)

7,480.34 -74.43 (-0.99%)

63,887.74 -2,947.80 (-4.41%)

10,574.52 2.28 (0.02%)

96.36 0.10 (0.10%)

110.37 0.25 (0.23%)

130.11 0.62 (0.47%)

0.59 0.00 (0.06%)